In the past, it was believed that the main reason for the difference in clinical prognosis between Asian and non-Asian gastric cancer patients was the adoption of different treatment methods and clinical management methods. However, a recent clinical trial shows that even if standard treatment methods are used, there are still differences in clinical prognosis between Asian and non-Asian gastric cancer patients. A transnational research team from the Singapore Genome Research Institute conducted the clinical study and found that the difference in clinical prognosis of gastric cancer is related to the different tumor immune markers between patients from Asian and non-Asian countries. The results show that, There are different gene markers between Asian and non-Asian gastric cancer patients, These gene Read More …